← Back to Search

Other

Pre- post-dietary intervention for Intermittent Fasting

N/A
Waitlist Available
Led By Stephen Ives, Ph.D.
Research Sponsored by Skidmore College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up (days 0 and 4)
Awards & highlights

Study Summary

This trial will study the effects of the Plexus 3-Day Reset on weight and metabolism.

Eligible Conditions
  • Intermittent Fasting
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~(days 0 and 4)
This trial's timeline: 3 weeks for screening, Varies for treatment, and (days 0 and 4) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in body weight
Secondary outcome measures
Change in augmentation index
Change in body fat (%)
Change in central blood pressure
+15 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pre- post-dietary interventionExperimental Treatment1 Intervention
Single arm pre-post dietary intervention (caloric restriction)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
3 day caloric restriction/metabolic reset
2022
N/A
~20

Find a Location

Who is running the clinical trial?

Skidmore CollegeLead Sponsor
18 Previous Clinical Trials
1,037 Total Patients Enrolled
Stephen Ives, Ph.D.Principal InvestigatorSkidmore College

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025